200 related articles for article (PubMed ID: 38338668)
61. Liraglutide With Metformin Therapy Ameliorates Hepatic Steatosis and Liver Injury in a Mouse Model of Non-alcoholic Steatohepatitis.
Chiu HY; Tsai SC; Tsai FJ; Lo YH; Cheng CC; Liu TY; Jhan SR; Yang JS; Chiu YJ
In Vivo; 2023; 37(3):1037-1046. PubMed ID: 37103096
[TBL] [Abstract][Full Text] [Related]
62. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
Schneider KM; Mohs A; Kilic K; Candels LS; Elfers C; Bennek E; Schneider LB; Heymann F; Gassler N; Penders J; Trautwein C
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646522
[TBL] [Abstract][Full Text] [Related]
63. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
Saleh DO; Ahmed RF; Amin MM
Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750
[TBL] [Abstract][Full Text] [Related]
64. Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice.
Jiang X; Jiang L; Shan A; Su Y; Cheng Y; Song D; Ji H; Ning G; Wang W; Cao Y
EBioMedicine; 2018 Nov; 37():307-321. PubMed ID: 30316865
[TBL] [Abstract][Full Text] [Related]
65. Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis.
Zhang J; Jiang D; Lin S; Cheng Y; Pan J; Ding W; Chen Y; Fan J
Life Sci; 2021 Apr; 270():119131. PubMed ID: 33516698
[TBL] [Abstract][Full Text] [Related]
66. Pharmacological and genetic increases in liver NADPH levels ameliorate NASH progression in female mice.
Rodriguez-Ramiro I; Pastor-Fernández A; López-Aceituno JL; Garcia-Dominguez E; Sierra-Ramirez A; Valverde AM; Martinez-Pastor B; Efeyan A; Gomez-Cabrera MC; Viña J; Fernandez-Marcos PJ
Free Radic Biol Med; 2024 Jan; 210():448-461. PubMed ID: 38036067
[TBL] [Abstract][Full Text] [Related]
67. Ubiquitin-specific peptidase 10 ameliorates hepatic steatosis in nonalcoholic steatohepatitis model by restoring autophagic activity.
Xin SL; Yu YY
Dig Liver Dis; 2022 Aug; 54(8):1021-1029. PubMed ID: 35288065
[TBL] [Abstract][Full Text] [Related]
68.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
69. Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress.
Lee GR; Lee HI; Kim N; Lee J; Kwon M; Kang YH; Song HJ; Yeo CY; Jeong W
J Cell Physiol; 2022 Sep; 237(9):3554-3564. PubMed ID: 35696549
[TBL] [Abstract][Full Text] [Related]
70. Melatonin alleviates diet-induced steatohepatitis by targeting multiple cell types in the liver to suppress inflammation and fibrosis.
Xu L; Li H; Zhang O; Zhang F; Song M; Ma M; Zhao Y; Ding R; Li D; Dong Z; Jin S; Han W; Ding C
J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36356262
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
Yang YL; Kuo HC; Wang FS; Huang YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
[TBL] [Abstract][Full Text] [Related]
72. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
[TBL] [Abstract][Full Text] [Related]
73. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
Yang G; Jang JH; Kim SW; Han SH; Ma KH; Jang JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316419
[TBL] [Abstract][Full Text] [Related]
74. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis.
Marcolin E; Forgiarini LF; Tieppo J; Dias AS; Freitas LA; Marroni NP
Arq Gastroenterol; 2011; 48(1):72-9. PubMed ID: 21537547
[TBL] [Abstract][Full Text] [Related]
75. Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease.
Oates JR; Sawada K; Giles DA; Alarcon PC; Damen MSMA; Szabo S; Stankiewicz TE; Moreno-Fernandez ME; Divanovic S
Front Immunol; 2023; 14():1095132. PubMed ID: 36875069
[TBL] [Abstract][Full Text] [Related]
76. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
Zhang L; Li HX; Pan WS; Khan FU; Qian C; Qi-Li FR; Xu X
Biomed Pharmacother; 2019 Feb; 110():571-581. PubMed ID: 30537674
[TBL] [Abstract][Full Text] [Related]
77. 6-Shogaol Ameliorates Liver Inflammation and Fibrosis in Mice on a Methionine- and Choline-Deficient Diet by Inhibiting Oxidative Stress, Cell Death, and Endoplasmic Reticulum Stress.
Yang AY; Kim K; Kwon HH; Leem J; Song JE
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257332
[TBL] [Abstract][Full Text] [Related]
78. Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism.
Miao H; Ouyang H; Guo Q; Wei M; Lu B; Kai G; Ji L
J Nutr Biochem; 2022 Aug; 106():109020. PubMed ID: 35472433
[TBL] [Abstract][Full Text] [Related]
79. Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats.
Karahan N; Işler M; Koyu A; Karahan AG; Başyığıt Kiliç G; Cırış IM; Sütçü R; Onaran I; Cam H; Keskın M
Turk J Gastroenterol; 2012 Apr; 23(2):110-21. PubMed ID: 22706738
[TBL] [Abstract][Full Text] [Related]
80. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization.
Jiang Q; Li Q; Liu B; Li G; Riedemann G; Gaitantzi H; Breitkopf-Heinlein K; Zeng A; Ding H; Xu K
Int Immunopharmacol; 2021 Jul; 96():107591. PubMed ID: 33812253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
